Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations

Naroa Ibarretxe-Bilbao
June 2010
Journal of Neurology, Neurosurgery & Psychiatry;Jun2010, Vol. 81 Issue 6, p650
Academic Journal
OBJECTIVE: To determine the course of cognitive deficits and the regional progression of brain atrophy in patients with Parkinson's disease (PD) with and without visual hallucinations (VH). METHODS: The authors performed MRI and neuropsychological assessment at entry to the study and at follow-up (mean±SD=29.91±5.74 months) in a sample of initially non-demented 12 PD patients with VH, 14 PD patients without VH and 12 healthy controls (HC). Grey-matter changes over time were assessed by means of voxel-based morphometry (VBM) and cognitive changes by an extensive neuropsychological battery. RESULTS: At follow-up, 75% of patients with VH developed dementia. The greatest decline was observed in verbal memory, semantic fluency, language comprehension and visuoperceptive functions. None of the patients without VH met criteria for dementia and did not show any worsening in cognitive functions over time. Patients with VH showed widespread limbic, paralimbic and neocortical grey-matter loss, whereas in the PD without VH group, grey-matter loss was restricted to a small region in the frontal cortex and cerebellum. The authors also found significant correlations between the changes in several cognitive functions and grey-matter loss over time in PD patients with VH. CONCLUSION: The presence of VH in PD determines a different cognitive outcome and a different pattern of progressive brain atrophy. PD patients with VH, unlike PD without VH, frequently develop dementia and show a widespread atrophy involving limbic, paralimbic and neocortical areas.


Related Articles

  • Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson’s disease with hallucinations. Goldman, Jennifer G.; Stebbins, Glenn T.; Dinh, Vy; Bernard, Bryan; Merkitch, Doug; deToledo-Morrell, Leyla; Goetz, Christopher G. // Brain: A Journal of Neurology;Mar2014, Vol. 137 Issue 3, p849 

    Visual hallucinations and dementia frequently complicate advanced Parkinson's disease, but whether they have the same neurobiological basis is unknown. Goldman et al. use structural MRI to study patients with and without hallucinations, matched for cognition. Hallucinations were associated with...

  • On visual hallucinations and cortical networks: a trans-diagnostic review. Carter, Rowena; ffytche, Dominic // Journal of Neurology;Jul2015, Vol. 262 Issue 7, p1780 

    Our current clinical approach to visual hallucinations is largely derived from work carried out by Georges de Morsier in the 1930s. Now, almost a century after his influential papers, we have the research tools to further explore the ideas he put forward. In this review, we address de Morsier's...

  • Coexistent Lewy body disease in a case of "visual variant of Alzheimer's disease". Tang-Wai, D. F.; Joseph, K. A.; Boeve, B. F.; Petersen, R. C.; Parisi, J. E.; Dickson, D. W.; Josephs, K A // Journal of Neurology, Neurosurgery & Psychiatry;Mar2003, Vol. 74 Issue 3, p389 

    Posterior cortical atrophy or the visual variant of Alzheimer's disease is a clinical syndrome with visual agnosia, some or all the components of Balint's syndrome, transcortical sensory aphasia, and Gerstmann's syndrome. Although pathologically heterogeneous, several necropsy studies on...

  • Visual hallucinations in the differential diagnosis of parkinsonism. Bertram, Kelly; Williams, David R. // Journal of Neurology, Neurosurgery & Psychiatry;Apr2012, Vol. 83 Issue 4, p448 

    Visual hallucinations (VH) occur commonly in Parkinson's disease (PD) and dementia with Lewy bodies (DLB) but are reported much less frequently in other neurodegenerative causes of parkinsonism, such as progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration...

  • α-Synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies. Neumann, Manuela; Adler, Silke; Schlüter, Oliver; Kremmer, Elisabeth; Benecke, Reiner; Kretzschmar, H. A. // Acta Neuropathologica;Nov2000, Vol. 100 Issue 5, p568 

    We studied a 27-year-old woman who died after a 6-year history of progressive dementia, dystonia, ataxia, apraxia, spasticity, choreoathetosis, visual and auditory hallucinations, and optic atrophy. Magnetic resonance imaging showed decreased intensity in the globus pallidus, substantia nigra,...

  • Selegiline.  // Reactions Weekly;6/27/2009, Issue 1258, p28 

    The article describes the case of a woman who experienced an isolated transient episode of visual hallucinations after she started receiving selegiline for suspected Parkinson's disease. The symptoms resolved when the drug was discontinued. She later reported other episodes of visual...

  • Hallucinations. Brasic, James Robert // Perceptual & Motor Skills;Jun98 Part 1, Vol. 86 Issue 3, p851 

    Studies the occurrence of hallucinations, focusing on functional neuroimaging. Occurrence of hallucinations; Localization assistance of hallucination; Persistent visual hallucinations of persons with Parkinson's disease; Association of hallucinations with persons suffering from Alzheimer's...

  • Parkinson's disease showing progressive conduction aphasia. Sakai, Kenji; Ono, Kenjiro; Harada, Hiromi; Shima, Keisuke; Notoya, Masako; Yamada, Masahito // Neurological Sciences;Apr2012, Vol. 33 Issue 2, p399 

    Patients with Parkinson's disease (PD) may develop progressive dementia late in their clinical course. Dementia in PD is mostly related to neuropathological findings of extensive Lewy bodies (LBs), with or without the coexistence of Alzheimer's disease (AD) pathology. Aphasia has been reported...

  • Study finds Parkinson's may affect heart nerves. Poet, Jonathan // Hudson Valley Business Journal;09/25/2000-10/09/2000, Vol. 11 Issue 16, p27 

    Reports on the results of a study which discovered how Parkinson's disease affects nerves in the heart as well the brain. Loss of nerve endings in part of the brain associated with the disease; Differentiation of Parkinson's from conditions with similar symptoms such as multiple system atrophy.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics